US Stock MarketDetailed Quotes

REVB Revelation Biosciences

Watchlist
  • 2.7400
  • +0.3100+12.76%
Close Mar 28 16:00 ET
  • 2.8700
  • +0.1300+4.74%
Post 18:29 ET
4.47MMarket Cap-5169P/E (TTM)

About Revelation Biosciences Company

Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.

Company Profile

SymbolREVB
Company NameRevelation Biosciences
Listing Date10/08/2020
Founded2019
CEOMr. James Rolke
MarketNASDAQ
Employees10
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4660 LaJolla Village Drive,Suite 100
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92122
Phone1-650-800-3717

Company Executives

  • Name
  • Position
  • Salary
  • James Rolke
  • Director and Chief Executive Officer
  • 479.59K
  • Chester Zygmont, III
  • Chief Financial Officer and Principal Accounting Officer
  • 339.14K
  • Dr. George F. Tidmarsh, M.D.,Ph.D.
  • Chairman of the Board
  • 75.00K
  • Jess Roper
  • Independent Director
  • 75.00K
  • Dr. Lakhmir S. Chawla, M.D.
  • Independent Director
  • --
  • Jennifer A. Carver, M.B.A.
  • Independent Director
  • 75.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg